Keyword: prostate cancer

News

Sanofi Can Look at Medivation’s Books

07.07.2016 - Under months of pressure from Sanofi as an acquisition target, Medivation has now agreed to allow the French drugmaker to look at its books. Sanofi announced on Jul. 5 it had...

News

Sanofi Offers $9 Billion for Medivation

29.04.2016 - As expected, French drugmaker Sanofi has made an unsolicited all cash, non-binding proposal bid to acquire US biopharmaceuticals firm Medivation. In a letter to the board of the...

News

Breakthrough Status for AstraZeneca Cancer Drug

01.02.2016 - The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to UK-Swedish drug maker AstraZeneca for its oral poly ADP-ribose polymerase (PARP)...

News

AstraZeneca’s Olaparib May Find New Market

30.10.2015 - In what is being called a “landmark clinical trial” of genetic oncology, UK researchers have discovered that AstraZeneca’s Lynparza (olaparib), approved in 2015 to treat ovarian...

Markets & Companies

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...

News

Bachem and Debiopharm Sign Follow-up Contract

09.12.2009 - Bachem and Debiopharm announced the conclusion of a follow-up agreement for the long-term supply of Triptorelin Pamoate. Bachem has been supplying Triptorelin Pamoate, the active...